Vaccines like Pfizer-BioNTech required ultra-low temperatures, which was a logistical challenge. Suddenly, companies had to ...

Most current vaccines must be stored between 2-8 ̊C, as accidental freezing can lead to reduced potency through agglomeration and degradation. Cold chain practices tend to overlook accidental freezing ...

It is noted that such thermal containers are necessary to comply with the conditions of the «cold chain» during ...

The collaboration licenses Emervax to use Kindeva’s microneedle array patch to administer vaccines developed using its RNA ...

Emervax Logo Kindeva Drug Delivery Logo By combining Kindeva's microneedle patches with Emervax's emxRNATM thermostable platfor ...

ROX Hi-Tech Limited Onboards John Bright as Executive Vice President to Drive Global Growth ...

The global temperature controlled pharmaceutical packaging solutions market is witnessing substantial growth, driven by ...

The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of mRNA vaccines introduced a new paradigm in ...

Kindeva Drug Delivery, a global CDMO, and Emervax, developer of a circular RNA-based vaccine platform (emxRNA), entered an ...